According to the latest report by IMARC Group, titled "Active Pharmaceutical Ingredients (API) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026," the global active pharmaceutical ingredients (API) market report reached a value of US$ 200.6 Billion in 2020. An active pharmaceutical ingredient (API) is an active component of a drug that plays a vital part in the formulation of pharmaceutical drugs. There are usually two different kinds of chemical ingredients present in most drugs, namely excipient and API. Various drugs can also contain multiple APIs to enhance the overall effect of the medicine on a patient.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request Free Sample Report: https://www.imarcgroup.com/active-pharmaceutical-ingredients-market/requestsample
Global Active Pharmaceutical Ingredients (API) Market Trends:
The global market is majorly driven by significant growth in the pharmaceutical industry. Furthermore, the rising geriatric population, which is highly susceptible to developing fatal medical conditions, is providing a thrust to market growth. Besides this, increasing investments by the key manufacturers to produce better-quality and highly effective APIs are creating a positive outlook for the market. Apart from this, the increasing number of blockbuster patent expiries across the globe has provided a boost to the market growth. Other factors, including the rising healthcare expenditure and the growing demand for APIs for biologicals, are also anticipated to contribute to the market growth. On account of the aforementioned factors, the market is anticipated to exhibit moderate growth during the forecast period (2021-2026).
Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/active-pharmaceutical-ingredients-market
Competitive Landscape with Key players:
The report has also analysed the competitive landscape of the market with some of the key players being.
- Pfizer, Inc.
- Novartis International AG
- Sanofi
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Teva Pharmaceutical Industries Ltd.
- ELI Lilly and Company
- GlaxoSmithKline
- Merck & Co., Inc.
- Abbvie Inc
Active Pharmaceutical Ingredients (API) Market Segmentation:
Our report has categorized the market based on region, drug type, manufacturer, synthesis and therapeutic application.
Breakup by Drug Type:
- Innovative Active Pharmaceutical Ingredients (API)
- Generic Active Pharmaceutical Ingredients (API)
Breakup by Manufacturer:
- Captive Manufacturers
- Merchant API Manufacturers
- Innovative Merchant API Manufacturers
- Generic Merchant API Manufacturers
Breakup by Synthesis:
- Synthetic Active Pharmaceutical Ingredients (API)
- Market Breakup by Type
- Innovative Synthetic APIs
- Generic Synthetic APIs
- Biotech Active Pharmaceutical Ingredients (API)
- Market Breakup by Type
- Innovative Biotech APIs
- Biosimilars
- Market Breakup By Product
- Monoclonal Antibodies
- Vaccines
- Cytokines
- Fusion Proteins
- Therapeutic Enzymes
- Blood Factors
- Market Breakup By Expression System
- Mammalian Expression Systems
- Microbial Expression Systems
- Yeast Expression Systems
- Transgenic Animal Systems
- Others
Breakup by Therapeutic Application:
- Oncology
- Cardiovascular and Respiratory
- Diabetes
- Central Nervous System Disorders
- Neurological Disorders
- Others
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
We are updating our reports, If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Competitive landscape, etc. Click request free sample report, the report will be delivered to you in PDF format via email within 24 to 48 hours after the payment confirmation.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
